What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Timing conversions into stablecoins can protect gains during drawdowns. This piece outlines indicators and decision points for choosing pivots.
10,225 articlesA MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Apple pushes to a fresh all-time high as AI-enabled products and a robust services ecosystem drive growth. The move w...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
SpaceX and Amazon share a blueprint for infrastructure growth, but their earnings paths diverge, forcing investors to...
SOXL surged earlier this year but pulled back sharply in the last month. Two pressure points that will shape its next...
As AI stocks surge, Wall Street may signal overvaluation. I break down the arguments, share why I disagree, and give ...
IBM shares plunged after a softer than expected Q2 outlook, triggering a sharp one day drop. Analysts remain split, w...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
Five cities are in a high-stakes chase to land a blockbuster deal tied to LeBron James, hoping for lasting local grow...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
A growing glut inventory way—how should savvy investors respond when supply rises and loan terms shift? This guide br...